Pharma distribution directory 2026

    Pharmaceutical Distributors in Indonesia

    Indonesia’s medicine path is an island-and-JKN story: Enseval, Millennium Pharmacon International and Tempo Scan Pacific still invoice most private apotek, Kimia Farma is both factory and state-linked PBF, and BPJS Kesehatan decides which pack a JKN patient will actually be dispensed.

    BPOM licenses manufacturers, importers and pedagang besar farmasi (PBF). A house without a current PBF licence is not a legal wholesaler, which is the first filter on this list. Enseval (Kalbe group) is the private book most principals still put first. MPI is the second listed PBF. Tempo Scan Pacific blurs manufacturing, distribution and retail. Kimia Farma’s distribution arm feeds its own apotek and selected public doors. JKN — the national health-insurance system run by BPJS Kesehatan — has pulled a large share of volume into e-catalogue and hospital formulary logic that a private PBF appointment does not automatically win. Outer-island coverage (Makassar, Medan, Balikpapan, Kupang) is where even Enseval branches thin and regional PBF or Kimia Farma outlets take the drop. BioNixus names the PBF, the BPJS door and the island, because a Jakarta apotek listing will not predict a Palembang hospital e-catalogue win.

    Updated September 2026 · BPOM (Badan Pengawas Obat dan Makanan) — licensed manufacturers, importers and pedagang besar farmasi as of September 2026 · 14 named accounts

    Request a proposal for IndonesiaBrowse the 14 companies

    PBF

    Licensed wholesaler class — the only legal private invoice path

    Enseval + MPI

    Two listed private books that still dominate apotek drops

    JKN / BPJS

    Insurance logic that steers hospital and puskesmas packs

    Islands

    Makassar, Medan and eastern depots as the coverage test

    Named accounts

    Top pharmaceutical distributors in Indonesia

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against BPOM (Badan Pengawas Obat dan Makanan) — licensed manufacturers, importers and pedagang besar farmasi (as of 2026-09-05).
    #CompanyHQ
    01Enseval Putera MegatradingJakarta
    02Millennium Pharmacon International (MPI)Jakarta
    03Tempo Scan Pacific (distribution)Jakarta
    04Kimia Farma distribution and apotekJakarta
    05BPOM (Badan POM)Jakarta
    06BPJS KesehatanJakarta
    07LKPP e-catalogue / hospital pharmacy departmentsJakarta / hospital seats
    08Kalbe Farma in-house adjacencyJakarta
    09Regional PBF — Medan and Makassar housesMedan / Makassar
    10Apotek K-24 and other bannersYogyakarta / national
    11District health offices (Dinkes) and puskesmas storesKabupaten seats
    12Dexa Medica / Soho distribution adjacencyJakarta / Palembang
    13DHL / TNT Indonesia life-science roomsJakarta
    14Hospital groups (Siloam, Mitra Keluarga) pharmacy inboundJakarta / Surabaya

    Primary research

    These are the distributors and wholesalers we map in Indonesia

    Choosing or auditing a distribution partner in Indonesia? BioNixus runs distributor due-diligence interviews, channel-share estimates and pharmacy-level availability checks. Proposal ready within 48 hours of a brief.

    Planning research in Indonesia?

    Primary research, market access & HEOR. Proposals within 48 hours.

    BioNixus research services

    How the market is structured

    PBF invoices, Kimia Farma doors and BPJS e-catalogue

    A multinational affiliate or a local industrial (Kalbe, Dexa, Soho, Sanbe) sells to Enseval, MPI, Tempo Scan’s distribution arm and a tail of regional PBF. Those houses deliver to independent apotek, small banners and private hospitals on credit that follows Indonesian banking rates. Kimia Farma’s PBF and its apotek chain are a state-linked loop: factory, warehouse, store. JKN patients are dispensed against BPJS rules and e-catalogue prices; hospital pharmacy departments in Jakarta, Surabaya and Bandung buy on that logic, and puskesmas follow district health-office contracts. BPOM serialization and batch rules sit on the invoice. Cold chain for vaccines and biologics concentrates in Jakarta, Surabaya and Medan, with 3PLs used for eastern islands when a PBF will not hold a validated room. Write the island cluster, the PBF and whether the outlet is JKN-facing. A “national Indonesian distributor” without those three is a Java study.

    Local

    Enseval, MPI, Tempo Scan’s PBF, Kalbe and Dexa adjacencies, and Medan–Makassar regional houses: Indonesian books that still invoice apotek across the islands.

    • Enseval Putera Megatrading
    • Millennium Pharmacon International (MPI)
    • Tempo Scan Pacific (distribution)
    • Kalbe Farma in-house adjacency
    • Dexa Medica / Soho distribution adjacency

    Multinational

    International 3PLs holding GDP rooms for affiliates. They store and fly east; they do not replace a PBF licence.

    • DHL / TNT Indonesia life-science rooms

    Regional

    ASEAN traders who treat Jakarta beside Kuala Lumpur or Manila, typically on selected imported specialty rather than JKN generics.

    Wholesalers, importers & 3PL

    BPOM, BPJS Kesehatan, LKPP e-catalogue, Kimia Farma’s SOE loop, Dinkes/puskesmas stores and chemist banners building DCs.

    • Kimia Farma distribution and apotek
    • BPOM (Badan POM)
    • BPJS Kesehatan
    • LKPP e-catalogue / hospital pharmacy departments
    • Regional PBF — Medan and Makassar houses
    • Apotek K-24 and other banners
    • District health offices (Dinkes) and puskesmas stores
    • Hospital groups (Siloam, Mitra Keluarga) pharmacy inbound

    What is moving

    What is moving pharma distribution in Indonesia

    JKN e-catalogue as the public demand gate

    BPJS rules and LKPP listings decide hospital and puskesmas packs. A private PBF win without an e-catalogue filing is a private-only story.

    Outer-island fill rates

    Enseval and MPI branches exist east of Java; fill rate often does not. Regional PBF and Kimia Farma outlets still close that gap, which is a coverage fact.

    Kimia Farma as factory-plus-PBF-plus-apotek

    The SOE loop internalises a slice of volume. Principals that only meet Enseval will under-see state-linked doors.

    Chemist banners centralising

    K-24 and peers add DC habits. Independent apotek remain the majority, but urban listing is already a banner meeting in several cities.

    BioNixus fieldwork

    How BioNixus studies pharmaceutical distributors in Indonesia

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Indonesia:
    • Apotek purchase-record audits in Jakarta, Surabaya, Medan and Makassar splitting Enseval, MPI, Tempo Scan and regional PBF invoices.
    • JKN hospital and puskesmas store checks: e-catalogue SKU versus what was actually dispensed, and which PBF invoiced inbound.
    • Kimia Farma apotek versus independent apotek price and availability on the same molecule in one Jakarta catchment.
    • Eastern-island 3PL and PBF branch walks on validated cold rooms versus ambient holds that still move tablets to Kupang.

    Questions

    Frequently Asked Questions

    Must a foreign manufacturer appoint one exclusive Indonesian PBF?

    Most affiliates appoint Enseval and MPI, sometimes Tempo Scan, and still negotiate Kimia Farma and hospital e-catalogue separately. Exclusive paper is uncommon outside specialty.

    What is a PBF and why does it matter?

    Pedagang besar farmasi is the licensed wholesaler class. BPOM issues the licence. Without it, the house cannot legally invoice an apotek or hospital pharmacy.

    How does BPJS Kesehatan change distribution?

    JKN reimbursement and e-catalogue prices steer which pack a hospital or puskesmas will order. The PBF delivers; BPJS decides the demand.

    Is Kimia Farma a competitor to Enseval or a public buyer?

    Both, in parts. It is a state-linked manufacturer, PBF and apotek chain. Map the warehouse door you need; do not file the whole group as “government.”

    What does BioNixus field on Indonesian pharmaceutical distribution?

    PBF invoice cuts in Jakarta, Surabaya, Medan and Makassar; BPJS/e-catalogue versus private apotek splits; Kimia Farma door checks; and puskesmas store walks in one kabupaten.

    Is company order a ranking?

    No. Names are grouped by private PBF, SOE loop, regulator, BPJS/e-catalogue, regional houses, banners and 3PLs so the next island visit is planned.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Indonesia. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: BPOM (Badan Pengawas Obat dan Makanan) — licensed manufacturers, importers and pedagang besar farmasi, consulted 2026-09-05. Company classification (Local / MNC / Regional / wholesalers, importers & 3pl) reflects ownership and role in Indonesia, not size.

    • BPOM PBF and manufacturer licensing notices, 2024–2026
    • BPJS Kesehatan and LKPP e-catalogue circulars; Kimia Farma and Enseval IDX filings, 2024–2026
    • IDX disclosures for MPI and Tempo Scan Pacific, 2024–2025
    • BioNixus Indonesia apotek, hospital and PBF fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need distributor and channel data in Indonesia?

    Coverage, credit terms, cold-chain capability and share of pharmacy purchases by wholesaler — from the pharmacies and hospitals themselves, not a directory.

    Planning research in Indonesia?

    Primary research, market access & HEOR. Proposals within 48 hours.